vaccine development | e-Asfalistiki
Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing
European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2 The EIB loan will support CureVac’s…
